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1.
Long-Term Prognosis of Percutaneous Transluminal Coronary
Angioplasty and Coronary Stenting

Table 1. Effects of Stent Implantation on Cardiac Events

Chen Jilin, Gao Runlin, Cai Qiangjun, Yang Yuejin, Qiao Shubin, Qin Xuewen,
Zhang Jun, Yao Min, et al. Cardiovascular Institute and Fu Wai Hospital,
CAMS & PUMC. Beijing 100037, China
In order to examine long-term efficacy of percutaneous transluminal coronary
angioplasty (PTCA), coronary stenting and to assess the factors affecting its
efficacy, 790 patients who underwent successful PTCA and PTCS+Stent in
this Hospital were followed by direct interview or letter. The rate of followup was 84.2% for the patients who should be followed. The period of followup was 0.9-12.7 (mean 3.5±2.4) years.

Recurrence of angina (%)
Total cardiac Events (%)
AMI (%)
Repeat PTCA (%)
CABG(%)

PTCA
(n=352)

PTCA plus
Stent (n=438)

2

P value

35.2
21.3
4.8
17.0
1.7

27.9
10.0
1.4
8.9
0.9

4.95
19.3
8.3
11.8
0.9

0.03
0.000
0.005
0.001
0.35

During follow-up, 4 (0.5%) patients died, 22 (2.8%) had nonfatal acute
myocardial infarction, 10 (1.3%) had coronary artery bypass surgery, and 98
(12.4%) had repeat PTCA. The rate of recurrent angina pectoris was 31.1%.
The cardiac event-free survival rate calculated by Kaplan-Meier method was
88.2% at 1 year and 80.6% at 12.7 years. Cox regression analysis showed that
there was a positive correlation between OMI history, implanting stent and
the risks of cardiac events, and there was a negative correlation between number
of diseased arteries and the risks of cardiac events. Compared to PTCA group,
patients with PTCA + stent had significantly lower rates of total cardiac events
(Table 1). In conclusion, the long-term efficacy of PTCA, especially PTCA +
stent in Chinese patients was very satisfactory, suggesting that PTCA + stent
therapy should be the first choice of revascularization for patients with coronary
heart disease.

2.
Application of Carotid Stenting in Treatment of Carotid Stenosis
- 9 Clinical Case Reports
Luo Jianfang, Chen Jiyan, Zhou Yinglin, Zhan Guohua, Wang Shou, Li Yuhui,
Tan Ning. Department of Cardiology, Guangdong Provincial Cardiovascular
Institute, #96 Dongchuan Road, Guangzhou 510100, China
Objective: To evaluate clinical outcome of stenting carotid stenosis in patients
with stroke.
Method: Carotid color echocardiography was performed in 9 patients
preprocedurally. Carotid and intracranial angiographies were done before,
after the procedure. Carotid color echocardiography was taken in 1st, 3rd, 6th
months post procedure. Self-expendable stents (Wallstent, Boston Scientific
Co.) were implanted to cover the target lesions. Neurological measurement
was taken periprocedurally and during follow-up.
Result: All of the patients aged more than 60 years and seven of them have
recurrent transient ischemic attack (TIA) or stroke, two of them were
symptomatic. Seven of them have associated severe coronary artery disease
(triple vessel disease). Selective angiogram showed that the luminal loss of
the stenotic lesion in all cases was >70%. The residual stenosis in all cases
was <5% after stenting. Technical success was achieved in all cases. One
patient had contralateral intracranial hemorrhage during the procedure and
died three days later. All the patients were neurological event free with patent
target arteries during the clinical and echographic follow-up study.
Conclusion: Carotid stenting could be a safe and feasible approach in
preventing and treating ischemic brain disease in patients with carotid stenosis.
It also may be a treatment of the combined ischemic heart and brain disease in
the future.
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3.
The Anti-proliferative Effects of Implantation of -emitting 103Pd
Radioactive Stent in Abdominal Arteries on Normal Rabbits
Zhou Yingling, Lin Shuguang, Li Gang. Department of Cardiology,
Guangdong Provencial Cardiovascular Institute, Guangzhou, China
Objective: To investigate the preventive role of implantation of -emitting
103
Pd radioactive stent on restenosis after artery injury.
Method: Fifty male New Zealand White rabbits were randomized into two
groups: I. Underwent ballon injury and stent deployment (Jomed stent 3.55.0×8mm) on abdominal arteries. II. Underwent ballon injury and -emitting
103
Pd radioactive stent deployment on abdominal arteries. All the animals were
sacrificed at 3, 7, 14, 28 and 56 days after stent deployment and their abdominal
arteries were harvested for further analysis.
Results: Under microscope, the scores of abdominal arterial injury were similar
between the two groups (P>0.05). Pathomorphometric analysis showed the
areas under external elastic membrane expressed no changes in both groups,
and there were no differences between the two groups. The neointima plus
medial areas and lumen areas showed significant differences between the two
groups from the end of 2 weeks. At the end of 8 weeks, compared with common
stent group, the lumen areas enlarged significantly and neointima hyperplasia
were restrained obviously in isotope stent group. The stenosis degrees were
reduced significantly in isotope stent group compared with common stent
group. Immunochemical study showed from 3 days to 2 weeks after the
procedure, the positive ratio (P/A, %) and the positive index of PCNA staining
were much more higher in common stent group than in isotope stent group.
Angiography results showed compared with the normal diameters in isotope
stent at the end of 8 weeks, the minimal lumen diameters and lumen stenosis
rates were significantly improved than those in common stent group. It was

consistent with the pathomorphometric analysis. Scanning eletron microscopy
observation: at the end of 4 weeks endothelium recovered almost completely
in common stent group but it could not recover completely until by the end of
8 weeks in isotope stent group. At the end of 2 weeks, the hyperplasia intima
and median mainly belonged to high or middle density and synthetic phenotype
in common stent group, but in isotope group, the majority of SMCs showed
middle-low density SMCS and contractile phenotype. Blood cells account
shows no changes thorough the whole study in both groups. Dosimetry
measurement showed no radioactive in periferial blood and stent adjacent
tissue. The radioactive of isotope stent showed a exponential decrease.
Conclusion: 103Pd radioactive stent implantation is effective and safety method
for reducing the stenosis rate after artery injury.

4.
Evaluation of Intravascular Ultrasound Guidance stent
Wenling Zhu, Chaolian Huang, Ding Han, Zhujun Shen, Xiuchun Jiang,
Yanhua Li. Peking Union Medical College Hospital, Chinese Academic of
Medical Sciences, PUMC
Objective: To determine the difference of the prognosis between groups using
intravascular ultrasound (IVUS) and angiography (CAG) guidance for stenting
in order to assess the evaluation of IVUS guidance stent.
Method: One hundred post - PTCA patients were divided into two groups of
stenting guided by IVUS and CAG at random. The patients were followed up
for six months and the end points were acute or subacute coronary thrombosis,
angina pectoris demonstrating in ECG to be in correspondence with target
vessels, revascularization and cardiogenic death.
Results: Fifty-three patients were in CAG guiding group (Group A) and fortyseven patients in IVUS guiding group (Group B). There were no significant
differences in sex, age, risk factors of CHD and medical therapy between two
groups (P>0.05). 34% of cases in Group A had cardiac events (1 acute stent
thrombosis, 11 angina pectoris, 3 revascularization and 3 cardiogenic death)
and there were no any acute or subacute thrombosis and other events in Group
B except 3 angina pectoris (6.4%) (P<0.05).
Conclusion: IVUS guiding stent implantation significantly reduced vascular
complications and events.
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Systematic Direct Angioplasty and Stent-Supported Direct
Angioplasty Therapy for Acute Myocardial Infarction: In-Hospital
and Long-Term Survival
Dayi HU, Tianchang LI, Sanqing JIA, Ming YANG, et al. The Heart Center,
Beijing Red Cross Chaoyang Hospital, Capital University of Medical Science,
Beijing 100020, China
Objectives: This prospective observational study was conducted to examine
the apparent impact of a systematic direct percutaneous transluminal coronary
angioplasty (PTCA) strategy on mortality in a series of 328 consecutive patients
with acute myocardial infarction (AMI).
Background: Previous studies have reported encouraging results with direct
PTCA in patients with AMI, but a biased case selection for PTCA may have
heavily influenced the observed outcomes.
Methods: All patients admitted with AMI were considered eligible for direct
PTCA, including those with the most profound shock, and no upper age limit
was used. The treatment protocol also included stenting of the infarct-related
artery for a poor or suboptimal angiographic result after conventional PTCA.
Results: Between Oct. 1996 and Dec. 1999, 328 consecutive pts. with AMI
who presented within 6 to 72 hrs if there was evidence of ongoing ischemia
treated with direct PTCA were evaluated. The angioplasty was considered to
be technically successful if there was a residual stenosis of less than 50% and
a flow of TIMI grade 2 or 3 at the end of the angioplasty procedure. The
successful rate was achieved in 316 pts. (96.3%, 316/328). The mean duration
from door-to-needle was 32 minutes. TIMI 3 flow was observed in 309 pts.
(94.2%, 309/328). 267 coronary stents were delivered in 255 IRA (77.7%,
255/328). The successful rate of stent delivery was 98.8% (264/267). The
indication for stent delivery included: selective 47.4% (127/267), bail-out

J HK Coll Cardiol, Vol 8

9.4% (25/267) and suboptimal 43.1% (115/267). Temporary AV block was
observed in 37 pts. (37/328). 10 pts. died from cardiogenic shock (3%) during
hospitalization. 296 pts. (90.2%) were followed up. The mean follow-up period
was 21 (6-42) months. 4 pts. died from heart failure. Recurrent ischemia
occurred in 34 cases (10.8%). Reinfarction were observed in 6 cases (0.19).
102 pts. adopted selective PTCA or CABG for multivessel disease.
Conclusion: Systematic direct PTCA, including stent-supported PTCA, can
establish a TIMI grade 3 flow and satisfied results in the great majority of
patients presenting with AMI.
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Percutaneous Balloon Aortic Valvuloplasty for the Treatment of
Congenital Valvular Aortic Stenosis
Gao Wei, Zhou Aiqing, Wang Rongfa. Shanghai Children's Medical Center,
University Hospital of Shanghai Second Medical University, Shanghai, China
Purpose: The aim of the present study was to assess the effect for the balloon
valvuloplasty for congenital valvular aortic stenosis (AS) in children.
Methods: 27 (mean aged of 6.09 years) children with AS had accepted the
treatment of PBAV. The ratios of balloon/valve were 0.95±0.08 for 19 cases
of typical AS and 1.00±0.11 for 8 cases of displastic AS. The patients were
evaluated by the gradients across aotic valves in pre- and post-PBAV and by
the Doppler ultrasonic cardiography during the follow-up period.
Results: The results showed that 15 (78.9%) of 19 cases with typical AS got
better outcome and the rest 4 cases (26.7%) had undergone the increase in P
after follow-up (P>50mmHg). 4 (50%) of 8 cases with dysplastic AS were
good and 3 cases (75.0%) gradient rose after follow-up. There was no moderate
to severe aortic insufficiency.

Table 2. Immediate results of PBAV in hypoplastic AS (8 cases)
Item

Before PBAV

After PBAV

t

p

LVSP (mmHg)
AOSP (mmHg)
P (mmHg)

206.88±56.82
92.88±5.51
114.00±57.27

161.38±48.82
126.50±23.07
61.13±38.01

4.12
3.98
4.70

<0.01
<0.01
<0.01

Conclusion: It is concluded that balloon aortic valvuloplasty provides safe
and significant hemodynamic and clinical improvement. The outcome of
PBAV for typical AS is better than displastic AS.

Hemodynamic change before and after PBAV
Table 1. Immediate results of PBAV in typical AS (19 cases)
Item

Before PBAV

After PBAV

t

p

LVSP (mmHg)
AOSP (mmHg)
P (mmHg)

166.53±29.16
96.47±18.61
70.05±17.36

129.05±16.07
110.84±16.55
19.32±12.0

5.50
3.96
12.86

<0.01
<0.01
<0.01

7.

8.

C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome

Unstable Angina (UA) Patients Benefit More From Low-dose,
Prolonged Urokinase (UK) Plus Heparin Than Hepauin Alone: A
Comparative Study-2

Yang Shengli, He Bingxian, He Xuelan, Zhang Wei, Yang Chunrong.
Department of Cardiovascular Medicine, Xinjiang Institute of Cardiovascular
Disease, First Affiliated Hospital, Xinjiang Medical University, Urumqi
830054, China
Background: Inflammation might promote the d evelop ment of
atherosclerosis, and C-reactive protein (CRP), an inflammatory marker, is
reported to predict risk of myocardial infarction (MI).
Objectives: We assessed the levels of CRP in patients with acute coronary
syndrome (ACS) [including unstable angina pectoris (UAP), acute myocardial
infarction (AMI) and sudden cardiac death (SCD)] compared with non-ACS
[including stable angina pectoris (SAP), old myocardial infarction (OMI) and
healthy volunteers] and sought to test whether CRP are associated with clinical
acute coronary syndrome.
Methods: Ultrasensitive immunoassay (rate nephelometry with the Beckman
Array multitest immunoassay system) was used to measure CRP levels in 91
patients with ACS (20 UAP, 69 AMI and 2 SCD) and 194 controls with nonACS (34 SAP, 25 patients with healing phase of AMI, 41 OMI and 94 healthy
subjects).
Results: CRP levels were higher in ACS group (18.50±23.98 mg/L [SE 2.51,
n=91]) compared with non-ACS group (3.89±7.14 mg/L [SE 0.51, n=194])
(p<0.01). Using Logistic Regression, CRP was a potent determinant of ACS
(OR=1.65).
Conclusion: These results suggest that CRP has a strong association with
ACS, and CRP is a risk factor of ACS.
Keywords: C-reactive protein, acute coronary syndrome, risk factors, unstable
angina pectoris, acute myocardial infarction, sudden cardiac death
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Jiayu Cui, Xiufeng Li, Yinghua Wang, Daoying Xu, Aixiang Liu, Ligeng
Zong, Rongbo Jia. Binzhou Prefectural People's Hospital, Shandong, China
There is still debate about thrombolytic therapy in UA patients. The aim of
this study was to research the efficacy of low-dose, prolonged UK+heparin
and compared with heparin alone.
This trial enrolled 176 UA patients. Eighty-eight patients were randomized to
the treatment with UK (100000u/d) +heparin (UFH or LMWH adjusted dose
with ACT 1.5-2.0 times baseline) was administered in 75% of the patients at
the physician's discretion. Eighty-eight UA patients were randomized to the
treatment with heparin alone as placebo. The usual conventional antianginal
medications (nitrates, aspirin -blockers, and calcium antagonists) were used,
if appropriate. Both treatment courses were ten days.
The primary endpoint was a composite of MI, recurrence of angina, or death.
At the end of three months, MI in the UK+heparin arm resulted in a 78.4%
reduction compared with heparin alone (2.2%, 2/88 vs 10.2%, 9/88).
Recurrence of angina in the UK+heparin arm resulted in a 71% reduction
compared with heparin alone (7.9%, 7/88 vs 27.2%, 24/88). Two patients
died, one in the UK+heparin arm, another in heparin alone arm. When
compared with run-in period both arms significantly reduced the frequency
and duration of angina.
Conclusion: Both arms markedly reduced the frequency and duration of
ischemic attacks in UA patients, UK+heparin was more effective than heparin
alone.
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Identification of Viable Myocardium by ST-segment Elevation and
Functional Improvement during Low-dose Dobutamine Testing
in Q Wave Myocardium Infarction
Li Xianlun, Li Xiao, Zheng Zhigang, Zhang Xiaoping. Cardiac Department,
China-Japan Friendship Hospital, Beijing 100029, China
Purpose: To evaluate the clinical value of ST-segment elevation and functional
improvement during low-dose dobutamine testing in assessing myocardial
viability.
Methods: 35 patients (mean [±SD] age 53±9 years) with Q wave myocardial
infarction underwent low-dose dobutamine electrocardiography and
echocardiography before revascularization, myocardial revascularization was
performed in all patients. Resting echocardiogram was repeated one month
after revascularization. A score model based on 16 segments and four grades
was used to assess left ventricular function. Functional improvement was
defined as a reduction of wall motion score 1 in 1 segments at follow up.
Dobutamine-induced ST-segment elevation was defined as a new or worsening
1 mm elevation, 80 ms after J point, in 2 infarct-related leads.
Results: Late functional improvement occurred in 18 patients (51%), STsegment elevation occurred in 14 patients (40%), ST-segment elevation
occurred more frequently during DST (dobutamine stress testing) in patients
with functional recovery at follow-up (11 of 18 vs 3 of 17); functional
improvement was common during DST in patient with functional recovery
after revascularization (16 of 18 vs 2 of 17). When the ST-segment elevation
and functional improvement during DST were considered together, among
12 patients who showed both the ST-segment elevation and functional
imp rovement, 1 1 pati ent s developed fu ncti onal recovery aft er
revascularization. The predictive value of the ST-segment elevation and

functional improvement during DST in assessing improvement of wall motion
after revascularization is shown the table.

ECG*
Echo#
ECG and Echo

Sens.

Spec.

Acc.

PPV

NPV

61
77
61

82
88
94

71
82
77

78
87
91

66
78
69

*ST-segment elevation during dobutamine stress testing.
#Improvement in contractility during dobutamine stress testing.
ECG=electrocardiography; Echo=echocardiography; Sens.=sensitivity; Spec.=specificity; NPV=negative
predictive value; PPV=positive predictive value; Acc.=accuracy.

Conclusion: Dobutamine-induced ST-segment elevation and functional
improvement are a valuable marker of myocardial viability. When the two
methods were considered, gave a better specificity.

10.

11.

Prevalence of Artherosclerotic Renal Artery Stenosis in Patients
with Coronary Artery Disease

High incidence of renal artery stenosis in patients undergoing
coronary angiography

Shen Zhujun, Shang Yunpeng, Zhu Wenling, Jiang Yuxing, Huang Chaolian.
Peking Union Medical College Hospital, Beijing, China

Jingang Yang, Dayi Hu, Tianchang Li, Yanhui Li, et al. The Heart Center,
Beijing Red Cross Chaoyang Hospital, Capital University of Medical Science,
Beijing 100020, China

Objective: To understand the prevalence of artherosclerotic renal artery
stenosis (ARAS) in patients with coronary artery disease (CAD) and the
relations among coronary artery disease, renal artery stenosis, hypertension
and renal insufficiency.
Method: 280 patients with coronary artery disease or suspected coronary
disease were carried out renal artery angiography after coronary angiography
over 1 year period.
Result: Of the total patient cohort, 58 patients (20.7%) had RAS, with 43
(15.3%) had significant RAS (50%), 3 (1.0%) were totally obstructed and
14 (5.0%) were bilateral. 47 patients (25.0%) were diagnosed as having RAS
among 188 CAD patients, with 36 (19.1%) had significant RAS. 7 patients
(7.6%) with significant RAS were found among 92 patients without CAD.
The prevalence of significant RAS was 19.6% and 7.9% as referred to with or
without hypertension, p<0.05. 10 patients (55.6%) had significant RAS in 18
patients with mild renal insufficiency as compared to 33 patients (12.6%) had
significant RAS in 262 patients with normal renal function, p<0.05. In the
subgroup of CAD, the prevalence of significant RAS were 15.3%, 17.1%,
25.4% in single vessel disease, two vessel disease and triple vessel disease
patients, p<0.05.
Conclusion: RAS is a frequent finding in patients with CAD, especially in
triple vessel disease patients. Hypertension is closely related to RAS, it should
be the risk factor of RAS, and can be the clinical manifestation of RAS. Renal
insufficiency without history of chronic glomerulonephritis may indicate RAS.
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Renal artery stenosis may be a cause of hypertension and a potential contributor
to progressive renal insufficiency. However, the prevalence of renal artery
disease in a general population is poorly defined. The purposes of this study
were to evaluate the prevalence of angiographically-determined renal artery
stenosis in a patient population undergoing routine coronary angiography,
and to identify the risk factors for renal artery stenosis. After coronary
angiography, nonselected renal arteriography was performed to screen for the
presence of renal artery stenosis. Over a 5-month period, a total of 188 patients
(128 males, 60 females) were studied and the mean age was 60.2 (29 to 78)
years. Renal artery narrowing was identified in 46 (24.5%) of patients.
Significant (> or = 50% diameter narrowing) renal artery stenosis was found
in 31 patients (16.5%) and insignificant (<50% diameter narrowing) stenosis
was found in 15 patients (8.0%). Significant unilateral stenosis was present in
21 (11.2%) patients and bilateral stenosis was present in 10 (5.3%). By
univariate and multivariate logistic regression analysis, the association of
clinical variables with renal artery stenosis was assessed. Multivariable
predictors included myocardial infarction (Wald 2 =12.63, P=0.0004),
congestive heart failure (Wald 2=10.06, P=0.0015), age (Wald 2=9.98, P=
0.0016), severity of coronary artery disease (Wald 2=15.25, P=0.0042) and
stroke (Wald 2=7.78, P=0.0053). The variables such as sex, body mass index,
smoking history, hyperlipidemia, renal insufficiency and diabetes mellitus
were not associated. In conclusion, renal artery stenosis is a frequent finding
in patients undergoing coronary angiography.
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13.

B i cava l Te chni que i n O rthotopi c Ho molo g ous Hea rt
Transplantation: Report of One Case

Effects of Losartan on Endothelin and Nitric Oxide in Patients
with Congestive Heart Failure

Wu Guanghua, Ma Liming, Dong Lijun, Yang Haiwei, Liu Hua and Chang
Li, et al. Department of Cardiothoracic Surgery, Affiliated Hospital of Jining
Medical College, Jining 272029, China

Jiang Ling, Wu Guanghua, Zhang Chuanhuan. Department of Cardiology,
the Affiliated Hospital of Jining Medical College, Jining 272109, Shandong,
China

In May 1999, we successfully performed bicaval technique for orthotopic
homologous heart transplantation in a male patient of 26 years old with endstage dilated cardiomyopathy. Now, it was shown normally that physiologic
function of the transplanted heart. The bicaval technique may preserve aotrial
contractility and sinus node function and may maintain the atrioventricular
valve competence. In contrast to the standard technique, the bicaval technique
offers a more physiologic RA size and contraction pattern throughout the
cardiac cycle. The donor heart was satisfactorily preserved with continuous
antegrade tepid blood cardioplegia. The continuous antegrade tepid blood
cardioplegia is a safe and efficacious method of myocardial protection. It
may minimized ischemic injury time. During transplantation procedure.
Combined antorejection therapy is preferable to a single medicine. The patient
have renal insufficiency just early postoperative period receive 17 days of
OKT3 monoclonal antibody <MAB>. This allows us to decrease the dose of
Cy A treatment after surgery.

Objective: To study the effects of losartan on plasma endothelin-1 (ET-1)
and nitric oxide (NO) levels in patients with congestive heart failure (CHF).
Methods: Sixty patients with congestive heart failure (New York Heart
Association [NYHA] functional classes II-IV) were randomised group for either
to losartan or to enalapril. Plasma angiotensin II (Ang II) and endothelin-1
concentrations were assessed by radioimmunoassay, and nitric oxide
concentrations were assessed by methods of nitric acid reductase.
Results: New York Heart Association functional class improved similarly
with losartan and enalapril treatment (versus baseline for both groups), 87%
of losartan-treated patients and 83% of enalapril-treated patients were class I
or II at the end of study compared with cardiac function at baseline. Plasma
endothelin-1 (109.19±28.13 pg/ml), nitric oxide (154.89±40.73 mol/L) and
angiotensin II (344.77±151.79 pg/ml) levels were higher in patients with
congestive heart failure than those in normal subjects (p<0.01). NO/ET-1 ratio
(1.38±0.58) was decreased in congestive heart failure. Plasma endothelin-1
and nitric oxide levels was reduced, thus, NO/ET-1 ratio was increased after 1
week and 12 weeks of therapy in two groups (p<0.05).
Conclusion: Congestive heart failure is characterized by increase of plasma
endothelin-1 and nitric oxide levels. This study showed that oral losartan
administered to patients with congestive heart failure resulted in beneficial
clinical and neurohormonal effects, with rather good tolerability.
Keywords: Nitric oxide; Endothelin; Heart failure; Congestive; Losartan;
Enalapril

14.
Coronary Angiographic Changes with Simvastatin Therapy
Wenling Zhu, Yong Zeng, Chaolian Huang, Zhujun Shen, Xiuchun Jiang,
Yanhua Li. Peking Union Medical College Hospital, Chinese Academic of
Medical Sciences, PUMC
Objective: To evaluate the coronary angiographic change with simvastatin
therapy.
Method: 73 patients with CAD, whether serum cholesterol levels elevated or
not were randomized to either simvastatin (n=39) or not (n=34) after coronary
angiography or successful PTCA. The repeated coronary angiogram and the
variation in arterial stenosis from computer assisted quantitation of coronary
cineangiogram was performed after one year follow-up. The end point was
(1) change of serum cholesterol levels (2) the variation of arterial stenosis (3)
cardiac events.
Results: Patients on simvastatin had a 15.4% reduction of serum cholesterol,
25.3% reduction of LDL-C, 15.2% reduction of TG and 11.5% increase of
HDL-C, while the serum cholesterol levels did not change in control group.
86 vessels in simvastatin group and 82 vessels in control group were analyzed.
20.7% of arterial lesion progression in simvastatin and 30.2% in control (P
<0.05) and 31.5% of progression risk decreased with simvastatin therapy.
Aggravation of arterial lesions were found in 20.5% of cases in simvastatin
group and 55.9% of cases in control (P<0.05). 63.3% of aggravation risk
decreased with simvastatin therapy. There was no difference in restenosis
after PTCA and stent deployment between two groups. The cardiac events
(AMI, revascularization and death) were found in 21 cases (61.8%) in
simvastatin group and 11 cases (28.2%) in control (P<0.05) during followup. 54.4% of the cardiac events risk decreased with simvastatin therapy.
25.6% of patients in simvastatin and 58.8% of patients in control occurred
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unstable angina pectoris (P<0.05).
Conclusions: (1) The serum cholesterol levels significantly decreased with
one year simvastatin therapy. (2) The variation in arterial stenosis from
computer assisted quantitation of coronary cineangiogram demonstrated that
progression risk of arterial lesions and aggravation risk in patients with CAD
significantly decreased with simvastatin therapy. (3) The cardiac events and
unstable angina pectoris significantly decreased with simvastatin therapy.
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